Cliff Asness's VCYT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 28,293 shares of Veracyte, Inc. (VCYT) worth $1.19 M, representing 0.00% of the portfolio. First purchased in 2019-Q1, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in VCYT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2019, adding 173,504 shares. Largest reduction occurred in Q2 2025, reducing 140,722 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Veracyte (VCYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veracyte (VCYT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1,071 | Add 3.93% | 28,293 | $42.10 |
| Q3 2025 | -27,945 | Reduce 50.66% | 27,222 | $34.33 |
| Q2 2025 | -140,722 | Reduce 71.84% | 55,167 | $27.03 |
| Q1 2025 | -34,410 | Reduce 14.94% | 195,889 | $29.65 |
| Q4 2024 | +40,007 | Add 21.02% | 230,299 | $39.60 |
| Q3 2024 | +131,875 | Add 225.75% | 190,292 | $34.04 |
| Q2 2024 | -9,544 | Reduce 14.04% | 58,417 | $21.67 |
| Q1 2024 | +14,122 | Add 26.23% | 67,961 | $22.16 |
| Q4 2023 | -14,596 | Reduce 21.33% | 53,839 | $27.51 |
| Q3 2023 | +16,269 | Add 31.19% | 68,435 | $22.33 |
| Q2 2023 | +27,565 | Add 112.05% | 52,166 | $25.47 |
| Q1 2023 | +2,287 | Add 10.25% | 24,601 | $22.30 |
| Q4 2022 | +22,314 | New Buy | 22,314 | $23.73 |
| Q1 2022 | -16,105 | Sold Out | 0 | $0.00 |
| Q4 2021 | -12,075 | Reduce 42.85% | 16,105 | $41.23 |
| Q3 2021 | +11,763 | Add 71.65% | 28,180 | $46.45 |
| Q2 2021 | -1,188 | Reduce 6.75% | 16,417 | $39.96 |
| Q1 2021 | +259 | Add 1.49% | 17,605 | $53.73 |
| Q4 2020 | -710 | Reduce 3.93% | 17,346 | $48.95 |
| Q3 2020 | -31,233 | Reduce 63.37% | 18,056 | $32.51 |
| Q2 2020 | -102,946 | Reduce 67.62% | 49,289 | $25.91 |
| Q1 2020 | -55,986 | Reduce 26.89% | 152,235 | $24.31 |
| Q4 2019 | -138,400 | Reduce 39.93% | 208,221 | $27.92 |
| Q3 2019 | -62,068 | Reduce 15.19% | 346,621 | $24.00 |
| Q2 2019 | +173,504 | Add 73.77% | 408,689 | $28.51 |
| Q1 2019 | +235,185 | New Buy | 235,185 | $25.02 |
Cliff Asness's Veracyte Investment FAQs
Cliff Asness first purchased Veracyte, Inc. (VCYT) in Q1 2019, acquiring 235,185 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Veracyte, Inc. (VCYT) for 26 quarters since Q1 2019.
Cliff Asness's largest addition to Veracyte, Inc. (VCYT) was in Q1 2019, adding 235,185 shares worth $5.88 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 28,293 shares of Veracyte, Inc. (VCYT), valued at approximately $1.19 M.
As of the Q4 2025 filing, Veracyte, Inc. (VCYT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Veracyte, Inc. (VCYT) was 408,689 shares, as reported at the end of Q2 2019.